Chris Kresser: The answer is yes. The markers, as you point out, are not exactly the same, but that doesn’t really matter because, as we discussed when we went over the organic acids panel, that is probably the least reliable or dependable in terms of what the evidence base tells us in terms of the relationship between those markers and clinical disease. I use it as another data point with all of the rest of the testing that we do, and I tend to look at it more as a gestalt, meaning if there are several markers that are positive and that adds to other positive findings, then it’s just another stick on the pile that tells us there’s something going on. I rarely will make clinical decisions based solely on a single marker on the organic acids panel, although there are certain markers within that panel, as we discussed, that are more reliable and diagnostic than others, like D-lactate, for example, which is being even investigated as a marker for SIBO. But overall, if you’re already ordering that panel, you can just take a glance at that malabsorption and dysbiosis section, and if you see several markers that are elevated, then that is establishing a trend in the direction of gut issues or dysbiosis that you can then piece together with the other types of testing that you’re doing, absolutely.